Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

444 Views

234. COVID-19: Vaccines: Saturday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Vaccines

(2346) Preliminary results of durable immune response induced by a self-amplifying mRNA (samRNA) SARS-CoV-2 vaccine candidate, GRT-R910, in adults previously vaccinated with mRNA or AZD1222 primary series

Saturday, October 14, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

Pedro Garbes, MD

SVP, Clinical Development
Gritstone bio, Inc.
Weston, Massachusetts, United States

A. Nagare, MBBS (he/him/his)

Director, clinical science
Gritstone bio, Inc
San Jose, California, United States
JK

JC Kuan, PhD

Gritstone Bio
Cambridge, Massachusetts, United States
CP

Christine Palmer, PhD

Gritstone Bio
Cambridge, Massachusetts, United States
KB

K. Bae, PhD

Gritstone bio, Inc
Cambridge, Massachusetts, United States
KJ

Karin Jooss, PhD

Head of Research & Development
Gritstone bio, Inc.
Emeryville, California, United States
AR

A. Rappaport, PhD

Gritstone bio, Inc
Emeryville, California, United States
MK

Melissa Kachura, BS

Gritstone Bio
Emeryville, California, United States
LK

L. Kraemer, PhD

Gritstone bio, Inc
Cambridge, Massachusetts, United States
HV

Harshni Venkatraman, MS

Gritstone Bio
Cambridge, Massachusetts, United States
JJ

Jason Jaroslavsky, MS

Gritstone Bio
Cambridge, Massachusetts, United States
SK

Sonia Kounlavouth, BS

Gritstone Bio
Cambridge, Massachusetts, United States
MM

M. Marrali, PhD

Gritstone bio, Inc
Cambridge, Massachusetts, United States

Meghan Hart, ALM

Associate Director
Gritstone bio
Boston, Massachusetts, United States